Trademark: 97346360
Word
TRAFEROX
Status Date
Monday, September 16, 2024
Filing Date
Monday, April 4, 2022
Published for Opposition
Tuesday, August 15, 2023
40 Manufacturing services for others in the fields of surgical and medical devices and surgical and medical consumables, namely, disposable surgical and medical equipment and supplies for use in organ transplant, transport, assessment and ex-vivo therapy
5 Solutions for medical purposes, namely, perfusion solutions for perfusion of organs, tissues and cells
44 Medical services, namely, medical assistance and advisory services in the field of organ transplant and organ assessment prior to transplant; the application of ex-vivo therapy protocols, namely, providing sustained perfusion, monitoring and assessment of organs for transplant for others
10 Surgical devices and instruments; Medical devices, instruments and consumables for organ transplant, transport, assessment and ex-vivo therapy, namely, sterile organ chambers for use in ex-vivo organ support, medical devices to regulate organ temperature, perfusion and oxygenation during organ transport and transplantation, instruments to assess and monitor organs for transplant and disposable accessories for the foregoing goods in the nature of tubesets being tubing for use with perfusion, cannulae, sterile bags, organ chambers, and transport coolers
42 Medical research services; scientific research and development; medical and scientific research in the field of organ transplants and ex-vivo therapy; compiling data for research purposes in the field of organ transplants and ex-vivo therapy; research and development in the field of organ transplants and ex-vivo therapy; research and development of new medical and surgical devices for others; providing information about medical and scientific research via a website; Software as a service (SAAS) services featuring software that automates perfusion device functionality and collects and collates organ perfusion data for use in medical and scientific research and development in the field of organ transplants and ex-vivo therapy; software as a service (SAAS) services featuring software using artificial intelligence and machine learning to assess perfused organ prior to transplant for use in the field of organ transplants and ex-vivo therapy; providing online non-downloadable software services that automate perfusion device functionality and collects and collates organ perfusion data for use in medical and scientific research and development in the field of organ transplants and ex-vivo therapy; providing online non-downloadable software using artificial intelligence and machine learning to assess perfused organ prior to transplant for use in the field of organ transplants and ex-vivo therapy; software development services
Apr 7, 2022
New Application Entered
Apr 8, 2022
New Application Office Supplied Data Entered
Jan 19, 2023
Assigned To Examiner
Jan 24, 2023
Non-Final Action Written
Jan 24, 2023
Non-Final Action E-Mailed
Jan 24, 2023
Notification Of Non-Final Action E-Mailed
Apr 24, 2023
Teas Response To Office Action Received
Apr 24, 2023
Correspondence Received In Law Office
Apr 25, 2023
Teas/Email Correspondence Entered
Jun 17, 2023
Non-Final Action Written
Jun 17, 2023
Non-Final Action E-Mailed
Jun 17, 2023
Notification Of Non-Final Action E-Mailed
Jun 29, 2023
Teas Response To Office Action Received
Jun 29, 2023
Correspondence Received In Law Office
Jun 30, 2023
Teas/Email Correspondence Entered
Jul 11, 2023
Examiner's Amendment Entered
Jul 11, 2023
Examiners Amendment -Written
Jul 11, 2023
Examiners Amendment E-Mailed
Jul 11, 2023
Notification Of Examiners Amendment E-Mailed
Jul 11, 2023
Approved For Pub - Principal Register
Jul 26, 2023
Notification Of Notice Of Publication E-Mailed
Aug 15, 2023
Published For Opposition
Aug 15, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 10, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 2, 2024
Sou Teas Extension Received
Apr 2, 2024
Sou Extension 1 Filed
Apr 2, 2024
Sou Extension 1 Granted
Apr 4, 2024
Notice Of Approval Of Extension Request E-Mailed
Sep 16, 2024
Sou Teas Extension Received
Sep 16, 2024
Notice Of Approval Of Extension Request E-Mailed
Sep 16, 2024
Sou Extension 2 Filed
Sep 16, 2024
Sou Extension 2 Granted
Trademark Alertz updated from USPTO on 2030-01-24
